Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

alcon cusi - aciclovir - eye ointment - 3 %

European Union - English - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - efavirenz - hiv infections - antivirals for systemic use - sustiva is indicated in antiviral combination treatment of human-immunodeficiency-virus-1 (hiv-1)-infected adults, adolescents and children three years of age and older.sustiva has not been adequately studied in patients with advanced hiv disease, namely in patients with cd4 counts < 50 cells/mm3, or after failure of protease-inhibitor (pi)-containing regimens. although cross-resistance of efavirenz with pis has not been documented, there are at present insufficient data on the efficacy of subsequent use of pi-based combination therapy after failure of regimens containing sustiva.

European Union - English - EMA (European Medicines Agency)

merck sharp & dohme b.v. - efavirenz - hiv infections - antivirals for systemic use - stocrin is indicated in antiviral combination treatment of human-immunodeficiency-virus-1 (hiv-1)-infected adults, adolescents and children three years of age and older.stocrin has not been adequately studied in patients with advanced hiv disease, namely in patients with cd4 counts < 50 cells/mm3, or after failure of protease-inhibitor (pi)-containing regimens. although cross-resistance of efavirenz with pis has not been documented, there are at present insufficient data on the efficacy of subsequent use of pi-based combination therapy after failure of regimens containing stocrin.

European Union - English - EMA (European Medicines Agency)

teva b.v. - efavirenz - hiv infections - antivirals for systemic use - efavirenz is indicated in antiviral combination treatment of human-immunodeficiency-virus-1 (hiv-1)-infected adults, adolescents and children 3 years of age and older.efavirenz has not been adequately studied in patients with advanced hiv disease, namely in patients with cd4 counts < 50 cells/mm3, or after failure of protease inhibitor (pi)-containing regimens. although cross-resistance of efavirenz with protease inhibitors (pis) has not been documented, there are at present insufficient data on the efficacy of subsequent use of pi-based combination therapy after failure of regimens containing efavirenz.

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

centaur pharmaceuticals private limited, india - aciclovir - ointment - 3%w/w, 0.02

Malta - English - Medicines Authority

the wellcome foundation - aciclovir - eye ointment - aciclovir 3 % (w/w) - ophthalmologicals

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - aciclovir 30 mg/g;   - eye ointment - 3% w/w - active: aciclovir 30 mg/g   excipient: white soft paraffin - treatment of herpes simplex keratitis.

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - aciclovir 3%{relative} - eye ointment - 3% w/w - active: aciclovir 3%{relative} excipient: white soft paraffin - treatment of herpes simplex keratitis.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

agepha pharma s.r.o. - aciclovir - eye ointment - 30mg/1gram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - aciclovir - eye ointment - 30mg/1gram